Article: Bioxel Pharma Inc. - Financial and Strategic Analysis Review.

M2 PRESSWIRE-4 May 2009-www.companiesandmarkets.com: Bioxel Pharma Inc. - Financial and Strategic Analysis Review(C)1994-2009 M2 COMMUNICATIONS LTD

RDATE:04052009

-www.companiesandmarkets.com adds new report: Bioxel Pharma Inc. - Financial and Strategic Analysis Review

Bioxel Pharma Inc. - Financial and Strategic Analysis Review

Summary

Bioxel Pharma Inc. (Bioxel) is a biopharmaceutical company. The company is focused on the manufacture and distribution of taxane active pharmaceutical ingredients (APIs) namely paclitaxel and docetaxel, which are widely used in cancer treatment, as well as its starting materials 9-DHB and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!